Dr Thomas Joseph Gal Jr, MD | |
740 S Limestone B317 Ear Nose And Throat, Lexington, KY 40536-0001 | |
(859) 257-5405 | |
(859) 257-4644 |
Full Name | Dr Thomas Joseph Gal Jr |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 31 Years |
Location | 740 S Limestone B317 Ear Nose And Throat, Lexington, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902884182 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 18540 (Alabama) | Secondary |
207Y00000X | Otolaryngology | 40491 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Kentucky Hospital | Lexington, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kentucky Medical Services Foundation, Inc | 5698689909 | 806 |
News Archive
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
Kaiser Health News: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal. And for some states, that move could have the benefit of reviving funding for state-run programs that insure low-income adults. As of April 1, states can apply for federal funding to expand their Medicaid programs to cover low-income people earning up to 133 percent of the poverty level, or $14,404 for an individual and $29,326.50 for a family of four.
Building on its worldwide reputation as a leader in neuroscience research, McGill University today joined with two leading Swiss research institutions - the University of Zurich (UZH) and the Swiss Federal Institute of Technology (ETHZ) - to enhance neuroscience research in a host of areas, in fields that include pain therapy, Alzheimer's disease, synapse modelling and repair, neuroimmunology and genetic mechanisms of brain diseases.
› Verified 9 days ago
Entity Name | Kentucky Medical Services Foundation, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
Kaiser Health News: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal. And for some states, that move could have the benefit of reviving funding for state-run programs that insure low-income adults. As of April 1, states can apply for federal funding to expand their Medicaid programs to cover low-income people earning up to 133 percent of the poverty level, or $14,404 for an individual and $29,326.50 for a family of four.
Building on its worldwide reputation as a leader in neuroscience research, McGill University today joined with two leading Swiss research institutions - the University of Zurich (UZH) and the Swiss Federal Institute of Technology (ETHZ) - to enhance neuroscience research in a host of areas, in fields that include pain therapy, Alzheimer's disease, synapse modelling and repair, neuroimmunology and genetic mechanisms of brain diseases.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Thomas Joseph Gal Jr, MD 740 S. Limestone, B317 Ear, Nose And Throat Clinic, Lexington, KY 40536-0284 Ph: (859) 257-5405 | Dr Thomas Joseph Gal Jr, MD 740 S Limestone B317 Ear Nose And Throat, Lexington, KY 40536-0001 Ph: (859) 257-5405 |
News Archive
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
Kaiser Health News: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal. And for some states, that move could have the benefit of reviving funding for state-run programs that insure low-income adults. As of April 1, states can apply for federal funding to expand their Medicaid programs to cover low-income people earning up to 133 percent of the poverty level, or $14,404 for an individual and $29,326.50 for a family of four.
Building on its worldwide reputation as a leader in neuroscience research, McGill University today joined with two leading Swiss research institutions - the University of Zurich (UZH) and the Swiss Federal Institute of Technology (ETHZ) - to enhance neuroscience research in a host of areas, in fields that include pain therapy, Alzheimer's disease, synapse modelling and repair, neuroimmunology and genetic mechanisms of brain diseases.
› Verified 9 days ago
Alberto N Laureano, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1720 Nicholasville Road, Suite 500, Lexington, KY 40503 Phone: 859-278-1114 Fax: 859-277-0541 | |
Dr. Amit B Patel, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone B317, Lexington, KY 40536 Phone: 859-257-5405 Fax: 859-257-5096 | |
Dr. Alok Tejinder-singh Saini, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 740 South Limestone Otolaryngology, Lexington, KY 40536 Phone: 859-257-5405 Fax: 859-257-5096 | |
Dr. Christopher Haywood Azbell, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 740 South Limestone Ear Nose & Throat Clinic, Lexington, KY 40536 Phone: 859-257-5405 | |
Dr. William M Parell, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2101 Nicholasville Rd, Ste. 103, Lexington, KY 40503 Phone: 859-278-0494 Fax: 859-275-5086 | |
Dr. Kenneth Charles Iverson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 740 South Limestone Kentucky Clinic C300, Lexington, KY 40536 Phone: 859-257-5405 Fax: 859-257-5096 | |
Dr. Bryce Noblitt, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-257-5097 |